Viewing Study NCT05005156


Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2025-12-25 @ 9:04 PM
Study NCT ID: NCT05005156
Status: COMPLETED
Last Update Posted: 2025-06-25
First Post: 2021-06-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV
Sponsor: Fundación Huésped
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module